General Information
Drug ID
DR00010
Drug Name
Enalapril
Synonyms
(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; Enalapril (INN); Enalapril (TN); N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline; N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline; Renitec (TN); Vasotec; Vasotec (TN)
Drug Type
Small molecular drug
Indication High blood pressure [ICD11: BA00] Approved [1]
Therapeutic Class
Antihypertensive Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5388962"></iframe>
3D MOL 2D MOL
Formula
C20H28N2O5
Canonical SMILES
CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O
InChI
InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1
InChIKey
GBXSMTUPTTWBMN-XIRDDKMYSA-N
CAS Number
CAS 75847-73-3
Pharmaceutical Properties Molecular Weight 376.453 Topological Polar Surface Area 95.9
Heavy Atom Count 27 Rotatable Bond Count 10
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
XLogP
-0.1
PubChem CID
5388962
PubChem SID
103179319 , 103928457 , 11112847 , 11335583 , 11360822 , 11364201 , 11366763 , 11369325 , 11372634 , 11373494 , 11377487 , 113955320 , 11461794 , 11485085 , 11489271 , 11491293 , 11491823 , 11495121 , 127931871 , 134358398 , 135012773 , 137100856 , 140098266 , 14779899 , 14877707 , 17185069 , 29214998 , 39404326 , 46507920 , 47365119 , 47588933 , 47588934 , 47810682 , 48110391 , 48184936 , 48415941 , 49698433 , 50073899 , 50103938 , 50103939 , 53787340 , 57362754 , 75931775 , 7979157 , 89736144 , 9191 , 92309084 , 93166909 , 96024588 , 99313640
ChEBI ID
ChEBI:4784
TTD Drug ID
D00SEB
DT(s) Transporting This Drug MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [2]
OATP1A2 Transporter Info Organic anion transporting polypeptide 1A2 Substrate [3]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [4]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [2]
PEPT1 Transporter Info Peptide transporter 1 Substrate [5]
PEPT2 Transporter Info Peptide transporter 2 Substrate [6]
References
1 Enalapril was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers. J Pharmacol Exp Ther. 2006 Jul;318(1):395-402.
3 Uptake of enalapril and expression of organic anion transporting polypeptide 1 in zonal, isolated rat hepatocytes. Drug Metab Dispos. 2000 Jul;28(7):801-6.
4 The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein. Hepatology. 1998 Nov;28(5):1341-6.
5 The intestinal H+/peptide symporter PEPT1: structure-affinity relationships. Eur J Pharm Sci. 2004 Jan;21(1):53-60.
6 Ethanol inhibits functional activity of the human intestinal dipeptide transporter hPepT1 expressed in Xenopus oocytes. Alcohol Clin Exp Res. 2008 May;32(5):777-84.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.